<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>02741nam a22005051i 4500</leader>
  <controlfield tag="001">000710822</controlfield>
  <controlfield tag="003">CaToSAGE</controlfield>
  <controlfield tag="005">20240202172917.0</controlfield>
  <controlfield tag="005">20170113114356.0</controlfield>
  <controlfield tag="006">m|||||o||d||||||||</controlfield>
  <controlfield tag="007">cr |||||||||||</controlfield>
  <controlfield tag="008">170109r20172003enka   fo     000 0 eng d</controlfield>
  <datafield tag="STA" ind1=" " ind2=" ">
   <subfield code="a">NEZPRACOVANÝ IMPORT</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
   <subfield code="a">9781526406521 (ebook) :</subfield>
   <subfield code="c">No price</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(OCoLC)1017714005</subfield>
  </datafield>
  <datafield tag="040" ind1=" " ind2=" ">
   <subfield code="a">CaToSAGE</subfield>
   <subfield code="b">eng</subfield>
   <subfield code="c">CaToSAGE</subfield>
   <subfield code="e">rda</subfield>
   <subfield code="e">pn</subfield>
   <subfield code="d">UtOrBLW</subfield>
  </datafield>
  <datafield tag="043" ind1=" " ind2=" ">
   <subfield code="a">n us</subfield>
  </datafield>
  <datafield tag="050" ind1=" " ind2="4">
   <subfield code="a">HD9675.H674</subfield>
   <subfield code="b">W944 2017</subfield>
  </datafield>
  <datafield tag="082" ind1="0" ind2="4">
   <subfield code="a">381.4561574</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
   <subfield code="a">Huang, Kathryn I. C.,</subfield>
   <subfield code="e">author.</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
   <subfield code="a">Wyeth Pharmaceuticals :</subfield>
   <subfield code="b">Premarin, Prempro and hormone replacement therapy (A) /</subfield>
   <subfield code="c">Kathryn I. C. Huang, Megan E. Vanaelstyn, James S. O'Rourke.</subfield>
  </datafield>
  <datafield tag="264" ind1=" " ind2="1">
   <subfield code="a">London :</subfield>
   <subfield code="b">SAGE Publications Ltd,</subfield>
   <subfield code="c">2017.</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
   <subfield code="a">1 online resource :</subfield>
   <subfield code="b">illustrations.</subfield>
  </datafield>
  <datafield tag="336" ind1=" " ind2=" ">
   <subfield code="a">text</subfield>
   <subfield code="b">txt</subfield>
   <subfield code="2">rdacontent</subfield>
  </datafield>
  <datafield tag="337" ind1=" " ind2=" ">
   <subfield code="a">computer</subfield>
   <subfield code="b">c</subfield>
   <subfield code="2">rdamedia</subfield>
  </datafield>
  <datafield tag="338" ind1=" " ind2=" ">
   <subfield code="a">online resource</subfield>
   <subfield code="b">cr</subfield>
   <subfield code="2">rdacarrier</subfield>
  </datafield>
  <datafield tag="490" ind1="1" ind2=" ">
   <subfield code="a">SAGE Knowledge. Cases</subfield>
  </datafield>
  <datafield tag="500" ind1=" " ind2=" ">
   <subfield code="a">Originally published: Huang, K. I. C., Vanaelstyn, M. E., &amp; ORourke, J. S. (2003). Wyeth Pharmaceuticals: Premarin, Prempro and hormone replacement therapy (A). 03-05(A). Notre Dame, IN: The Eugene D. Fanning Center for Business Communication, Mendoza College of Business, University of Notre Dame.</subfield>
  </datafield>
  <datafield tag="520" ind1="8" ind2=" ">
   <subfield code="a">Millions of women worldwide between the ages of 45 and 55 experience the effects of menopause and have sought both treatment and relief in the form of hormone replacement therapy. Wyeth Pharmaceuticals, a division of Wyeth, Inc., is the market leader in prescription drug treatment for menopause with Premarin, a blend of natural estrogens (for women who have had a hysterectomy), and Prempro, a one-tablet hormone replacement therapy consisting of natural estrogens plus progestin. A stunning set of results from the Womens Health Initiative, released in the summer of 2002, however, challenges conventional approaches to treatment and poses a significant threat to Wyeth share price and market leadership.</subfield>
  </datafield>
  <datafield tag="588" ind1=" " ind2=" ">
   <subfield code="a">Description based on XML content.</subfield>
  </datafield>
  <datafield tag="655" ind1=" " ind2="7">
   <subfield code="a">elektronické knihy</subfield>
   <subfield code="7">fd186907</subfield>
   <subfield code="2">czenas</subfield>
  </datafield>
  <datafield tag="655" ind1=" " ind2="9">
   <subfield code="a">electronic books</subfield>
   <subfield code="2">eczenas</subfield>
  </datafield>
  <datafield tag="610" ind1="2" ind2="0">
   <subfield code="a">Wyeth (Firm)</subfield>
  </datafield>
  <datafield tag="610" ind1="2" ind2="0">
   <subfield code="a">Women's Health Initiative (U.S.)</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
   <subfield code="a">Pharmaceutical industry</subfield>
   <subfield code="z">United States.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
   <subfield code="a">Menopause</subfield>
   <subfield code="x">Hormone therapy</subfield>
   <subfield code="z">United States.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Vanaelstyn, Megan E.,</subfield>
   <subfield code="e">author.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">O'Rourke, James S.,</subfield>
   <subfield code="d">1946-</subfield>
   <subfield code="e">author.</subfield>
  </datafield>
  <datafield tag="830" ind1=" " ind2="0">
   <subfield code="a">SAGE Knowledge.</subfield>
   <subfield code="p">Cases.</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="3">SAGE Knowledge</subfield>
   <subfield code="u">https://sk.sagepub.com/cases/wyeth-pharmaceuticals-premarin-prempro-and-hrt-a</subfield>
   <subfield code="y">Plný text</subfield>
  </datafield>
  <datafield tag="BAS" ind1=" " ind2=" ">
   <subfield code="a">SBC</subfield>
  </datafield>
  <datafield tag="BAS" ind1=" " ind2=" ">
   <subfield code="a">EB</subfield>
  </datafield>
  <datafield tag="993" ind1=" " ind2=" ">
   <subfield code="x">NEPOSILAT</subfield>
   <subfield code="y">EB</subfield>
  </datafield>
 </record>
</collection>
